Kanye West and Gap agree to a multi-year deal for Yeezy line
Kanye West and Gap have agreed to a multi-year deal to create a clothing line for the entertainers famed Yeezy line. …read more […]
Kanye West and Gap have agreed to a multi-year deal to create a clothing line for the entertainers famed Yeezy line. …read more […]
A Hyliion IPO is coming to the markets. The company announced a reverse-merger. This comes after the successful merger and public debut of rival Nikola. Now, investors want to know if Hyliion stock is the next big hit.
But is Hyliion a good investment? Here’s what we know…
Hyliion IPO: The Business
CEO Thomas Healy founded Hyliion (Hi-LEE-on) in 2015. Healy is a mechanical engineer and motorsports racer. His mission is to bring hybrid technology to tractor trailers. Hyliion is the industry leader in Class 8 electrification. This includes cement trucks, dump trucks and freightliners. Hyliion designs, develops and sells electrified powertrain …read more […]
(Bloomberg) — The implosion of Wirecard AG in one of the biggest financial scandals in German corporate history leaves creditors who lent it as much as 3.2 billion euros ($3.6 billion) wondering if they’ll ever see their money again.The company filed for court protection from creditors on Thursday and there’s 1.9 billion euros missing from its balance sheet. Administrators face a long and complex task picking through the rubble of the first insolvency by a member of Germany’s main stock index.What comes next?The insolvency court in Munich needs to formalize the process and appoint an administrator. While the exact time …read more […]
Of the hundreds of wealth-building strategies I’ve tried over the years, the best one was also the simplest: Make sure you get a little bit richer every day.
This thought occurred to me more than 30 years ago. I’d recently decided to become rich, and that decision had me reading and thinking about wealth building day and night.
I had daily fantasies of getting rich in all sorts of fancy ways. But deep down inside, I knew complicated strategies were not for me.
When it came to making money, I was extremely risk-averse. In the race to a multimillion-dollar retirement, I was a …read more […]
One thing we could say about the analysts on Soligenix, Inc. (NASDAQ:SNGX) – they aren’t optimistic, having just made… …read more […]
Top news and what to watch in the markets on Friday, June 26, 2020. …read more […]
Chief executives of major airlines in the United States will confer with Vice President Mike Pence to discuss a range of issues related to the ongoing pandemic.What Happened The CEOs of American Airlines Group Inc (NASDAQ: AAL), Delta Air Lines, Inc (NYSE: DAL), Southwest Airlines Co (NYSE: LUV), United Airlines Holdings Inc (NASDAQ: UAL) and JetBlue Airways Corporation (NASDAQ: JBLU) will meet with the Vice President at the White House on Friday. The chief executives will discuss restrictions on U.S. travelers to be imposed by the European Union, temperature checks at U.S. airports, contact tracing airline passengers, and the likely …read more […]
(Bloomberg) — Months before Wirecard AG admitted that it was missing more than $2 billion in cash, the payments company was racing to load up on funds, adding debt and offering market-beating interest rates to clients who made deposits.In September, it issued its first investment-grade bond, raising 500 million euros ($561 million). Shortly after, it sold a 900 million-euro convertible bond with the help of Softbank Group Corp., which had pledged its backing earlier that year in a display of support after allegations of accounting irregularities surfaced.Some of the money was earmarked to pay down an existing 1.75 billion-euro credit …read more […]
(Bloomberg) — Visa Inc. and Mastercard Inc. are considering revoking Wirecard AG’s ability to process payments on their networks in a move that would cause further pain for the firm after it started insolvency proceedings.The world’s largest payment networks have begun reaching out to some Wirecard clients to prepare them for the possibility, according to people familiar with the matter, who asked not to be named because the information isn’t public.“We continue to closely monitor developments and assess new information as it becomes available,” Visa said in a statement. “Our priority is, and will always be, maintaining the integrity of …read more […]
Shares in sports betting company DraftKings (DKNG) have exploded by an incredible 237% since its Nasdaq debut in April. So it’s perhaps not surprising that insiders have taken advantage of this rally as quickly as possible. Although the extent to which the stock has been offloaded is still eyebrow-raising- with a whopping $596 million-worth of shares sold on June 23, according to a June 25 filing.Most notably, co-founder Paul Liberman has just sold $31 million worth of DKNG stock, leaving him with a $15 million holding. Robins Jason sold $70 million of DraftKings stock, while director Hany Nada sold off …read more […]
Shares in Vaxart (VXRT) exploded by 96% in Thursday’s trading, and continued to rally a further 27% after-hours, after the biotech announced a deal for its oral Covid-19 vaccine.The company revealed that it has now signed a Memorandum of Understanding with Attwill Medical Solutions Sterilflow, affirming the parties’ intent to establish AMS as a resource for lyophilization development and large-scale manufacturing including tableting and enteric coating for Vaxart’s oral COVID-19 vaccine.AMS will be assigning dedicated resources and equipment for the scale up and commercial production of the vaccine upon entering a formal agreement, Vaxart said.“We believe AMS’ experience coupled with …read more […]
Zogenix, Inc (ZGNX) has announced that the U.S. Food and Drug Administration (FDA) has finally approved Fintepla (fenfluramine) oral solution, CIV for the treatment of seizures associated with Dravet syndrome in patients 2 years of age and older.The drug will now be launched through a restricted distribution program, and is expected to be available through Zogenix’s specialty pharmacy partner by the end of July.“The approval of Fintepla by the FDA is a significant milestone” cheered Stephen Farr, CEO of Zogenix. “We began this global development program nearly six years ago after researchers in Belgium recognized the potential of fenfluramine, a …read more […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.